| EAE-Vehicle | EAE-FTY720 | p value | |
---|---|---|---|---|
Non-responder | Responder | |||
Clinical parameters | ||||
 Maximum score | 3 (2.25–3) | 3 (3–3) | 2.25* (1.25–2.63) |  < 0.01 |
 dpi peak | 15 (14–17) | 15 (13–15) | 15 (14–16) | ns |
 Severity index | 0.75 (0.50–1) | 0.75 (0.60–1) | 0.63 (0.33–0.69) | ns |
 Peak accumulated score | 6.5 (5.63–9) | 7 (6.50–9.75) | 4.5* (3–6.63) |  < 0.05 |
 Total accumulated score | 37.25 (23–45.38) | 41.38 (34.38–45.50) | 18* (10.90–24.75) |  < 0.001 |
 % Recovery | 25 (12.5–33.30) | 8.33 (0–25) | 75* (62.50–80.95) |  < 0.001 |
 Recovery index | 0.09 (0.04–0.17) | 0.04 (0–0.09) | 0.17* (0.13–0.22) |  < 0.01 |
 Residual score | 2.25 (1–2.63) | 2.75 (2.25–3) | 0.5* (0.5–0.75) |  < 0.001 |
Spleen | ||||
 % CD3+/Total blood cells | 15.15 ± 0.97 | 15.68 ± 3.27 | 10.13 ± 0.77* |  < 0.01 |
 % CD4+/Total blood cells | 9.11 ± 0.64 | 10.51 ± 2.17 | 7.20 ± 0.56* |  < 0.05 |
 % CD8+/Total blood cells | 4.98 ± 0.36 | 4.47 ± 0.91 | 2.46 ± 0.21* |  < 0.001 |
 % CD3 CD25+/Total blood cells | 1.32 ± 0.08 | 1.33 ± 0.25 | 1.04 ± 0.07* |  < 0.05 |
 % CD3 CD69+/Total blood cells | 1.77 ± 0.12 | 2.24 ± 0.31 | 1.78 ± 0.10 | ns |